Watson Pharmaceuticals
May 09, 2012 at 15:36 | Source: Reuters
Jan 24, 2012 at 12:36 | Source: Reuters
Jan 24, 2012 at 12:34 | Source: Moneycontrol.com
Jan 06, 2012 at 15:08 | Source: None
Dec 22, 2011 at 12:25 | Source: CNBC-TV18
News across the web »
May 18, 2012 at 20:01 | Source: Wall Street Journal
May 01, 2012 at 13:56 | Source: Business Today
Apr 30, 2012 at 18:07 | Source: Market Watch
Apr 28, 2012 at 21:42 | Source: The Hindu BusinessLine
Apr 28, 2012 at 12:32 | Source: Market Watch
Interact & exchange stock tips & market info »
Related News »
(Reuters) - Auxilium Pharmaceuticals Inc sued Watson Pharmaceuticals Inc alleging that it infringed patents related to Auxilium's testosterone gel Testim. A unit of Watson had filed with U.S. health regulators last month for the approval of a ...
May 24, 2012 at 12:16 | Source: Chicago Tribune
PARSIPPANY, N.J., May 25, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty global pharmaceutical company, announced today that Siggi Olafsson, Watson's President of Global Generics, will provide an overview and update of ...
May 25, 2012 at 13:19 | Source: 4-traders (press release)
Wells Fargo upgraded Watson Pharmaceuticals (NYSE: WPI) from Market Perform to Outperform, raising price target range from $75-79 to $84-90. Analyst, Michael Tong, said, "We have had a positive outlook on WPI's proposed Actavis acquisition. However, we ...
May 24, 2012 at 11:18 | Source: StreetInsider.com
Watson Pharmaceuticals, Inc., (Watson) is a specialty pharmaceutical company that develops, manufactures and markets branded and generic pharmaceutical products in the field of central nervous system, hormones and synthetic substitutes, cardiovascular ...
May 19, 2012 at 17:08 | Source: Transworld News
Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Testosterone ...
May 25, 2012 at 04:15 | Source: News-Medical.Net
May 24, 2012 (SmarTrend(R) Upgrades/Downgrades via COMTEX) -- Watson Pharmaceuticals (NYSE:WPI) was upgraded from Market Perform to Outperform at Wells Fargo today. The stock closed yesterday at $70.71 on volume of 1.5 million shares, below ...
May 24, 2012 at 12:44 | Source: TMCnet
NEW YORK (AP) -- Watson Pharmaceuticals shares rose Thursday as Wells Fargo upgraded its rating, citing the company's acquisition of a former competitor. THE SPARK: Analyst Michael Tong raised his rating to "Outperform" from "Market Perform."
May 26, 2012 at 17:57 | Source: Yahoo Finance
PARSIPPANY, N.J., May 9, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug ...
May 26, 2012 at 17:35 | Source: Yahoo Finance
Shares of Watson Pharmaceuticals (NYSE:WPI) have bearishly opened below the pivot of $71.28 today and have reached the first support level of $70.29. Analysts will be watching for a cross of the next downside pivot targets of $69.58 and $67.88. In the past ...
May 23, 2012 at 17:03 | Source: Financial News Network Online
(RTTNews.com) - Watson Pharmaceuticals Inc. (WPI) confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application or ANDA with the U.S. Food and Drug Administration or FDA seeking approval to market ...
May 25, 2012 at 01:23 | Source: NASDAQ